ODYSSEY THERAPEUTICS ANNOUNCES ORAL PRESENTATION OF ADDITIONAL PHASE 2A INDUCTION DATA FOR OD-001 IN ULCERATIVE COLITIS AT UEG WEEK 2026

Reuters · 2d ago

Please log in to view news